In Prevention of Japanese Encephalitis Japanese encephalitis is an infection of the brain caused by the Japanese encephalitis virus (JEV), a virus spread by the bite of infected mosquitoes. In most cases, the infection is mild but in serious cases the symptoms may include headache, vomiting, fever, confusion and seizures. Jenvac Vaccine works by causing the body to produce its own protection (antibodies) against the virus. This vaccine is generally recommended for individuals who are traveling to areas where this infection is common. However, while traveling, use insect repellent, wear long-sleeved shirts and pants, treat clothing and gear, and get vaccinated before traveling, if vaccination is recommended for you.
Caution is advised when consuming alcohol with Jenvac Vaccine. Please consult your doctor.
Jenvac Vaccine may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Jenvac Vaccine should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
It is not known whether Jenvac Vaccine alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Jenvac Vaccine is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Jenvac Vaccine may not be needed in these patients. Please consult your doctor.
Jenvac Vaccine is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Jenvac Vaccine may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Biological E Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)